HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Tsutsumi Selected Research

diisopropanolnitrosamine

12/2001FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
9/2001Elevated expression of transforming growth factor betas and the tumor necrosis factor family in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
1/2001Absence of PTEN/MMAC1 gene mutations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
12/2000Mutations of adenomatous polyposis coli and beta-catenin genes during progression of lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
11/2000Mutations and reduced expression of the transforming growth factor-beta receptor II gene in rat lung adenocarcinomas induced by N-nitrosobis-(2-hydroxypropyl)amine.
10/2000Elevated expression of interleukins in lung adenocarcinomas induced by N-Nitrosobis(2-hydroxypropyl)amine in rats.
10/2000Mutations of the Smad2 and Smad4 genes in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
2/2000Increased expression of cyclooxygenase-2 protein in rat lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine.
2/2000Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Tsutsumi Research Topics

Disease

12Adenocarcinoma
12/2001 - 01/2000
11Neoplasms (Cancer)
06/2018 - 01/2000
8Carcinogenesis
07/2001 - 02/2000
7Hyperplasia
08/2001 - 01/2000
6Adenocarcinoma of Lung
12/2001 - 10/2000
4Hepatocellular Carcinoma (Hepatoma)
01/2016 - 01/2000
4Fibrosis (Cirrhosis)
05/2007 - 06/2001
3Carcinoma (Carcinomatosis)
12/2001 - 01/2000
3Adenoma (Adenomas)
01/2001 - 02/2000
2Genomic Instability
10/2010 - 01/2001
2Carotid Stenosis (Carotid Artery Stenosis)
09/2008 - 08/2006
2Colonic Neoplasms (Colon Cancer)
12/2001 - 01/2001
2Colorectal Neoplasms (Colorectal Cancer)
12/2001 - 01/2001
2Melanoma (Melanoma, Malignant)
08/2001 - 06/2001
2Lymphangioleiomyomatosis (Lymphangiomyomatosis)
08/2001 - 06/2001
2Tuberous Sclerosis (Bourneville's Disease)
08/2001 - 06/2001
2Alcoholic Liver Diseases (Alcoholic Liver Disease)
06/2001 - 04/2000
1Opioid-Induced Constipation
06/2018
1Insulin Resistance
05/2015
1Dyslipidemias (Dyslipidemia)
05/2015
1Hyperglycemia
05/2015
1AIDS-Related Complex (ARC)
09/2008
1Pathologic Constriction (Stenosis)
09/2008
1Aneurysm (Aneurysms)
08/2006
1Intracranial Embolism
01/2006
1Stroke (Strokes)
01/2006
1Pleural Effusion (Pleural Effusions)
02/2004
1Neoplasm Metastasis (Metastasis)
12/2001
1Alcoholism (Alcohol Abuse)
11/2001
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2001
1Hamartoma
08/2001
1Chronic Hepatitis (Chronic Active Hepatitis)
08/2001
1Myeloid Leukemia (Leukemia, Myelocytic)
08/2001
1Liver Diseases (Liver Disease)
08/2001
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2001
1Lung Neoplasms (Lung Cancer)
02/2001
1Spontaneous Rupture
01/2001
1Liver Cell Adenoma (Hepatocellular Adenoma)
01/2001

Drug/Important Bio-Agent (IBA)

9diisopropanolnitrosamineIBA
12/2001 - 02/2000
7Proteins (Proteins, Gene)FDA Link
05/2007 - 02/2000
5Messenger RNA (mRNA)IBA
05/2007 - 10/2000
3Codon (Codons)IBA
12/2001 - 10/2000
3RNA (Ribonucleic Acid)IBA
01/2001 - 10/2000
3Transforming Growth Factor beta (TGF-beta)IBA
01/2001 - 10/2000
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016 - 09/2001
2Biomarkers (Surrogate Marker)IBA
05/2015 - 11/2001
2AminesIBA
12/2001 - 03/2000
2Ribonucleases (Ribonuclease)IBA
09/2001 - 10/2000
2lipoarabinomannan (LAM)IBA
08/2001 - 06/2001
2trans-sodium crocetinate (crocetin)IBA
08/2001 - 06/2001
2Monoclonal AntibodiesIBA
08/2001 - 06/2001
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2001 - 01/2001
2beta CateninIBA
07/2001 - 12/2000
2nitrosobis(2-oxopropyl)amine (NBOP)IBA
07/2001 - 10/2000
2CDAA (Randox)IBA
01/2001 - 04/2000
2Choline (Choline Chloride)IBA
01/2001 - 04/2000
2Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
01/2001 - 11/2000
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2001 - 04/2000
2Amino AcidsFDA Link
01/2001 - 04/2000
1Narcotic Antagonists (Opioid Antagonists)IBA
06/2018
1naldemedineIBA
06/2018
1AdipokinesIBA
05/2015
1Advanced Glycation End ProductsIBA
05/2015
1AdiponectinIBA
05/2015
1Atorvastatin (Lipitor)FDA Link
05/2015
1Single-Stranded DNA (DNA, Single Stranded)IBA
10/2010
1Phenobarbital (Luminal)FDA Link
09/2008
1Transforming Growth Factor beta1 (TGF beta 1)IBA
05/2007
1Dimethylnitrosamine (Nitrosodimethylamine)IBA
05/2007
1Small Interfering RNA (siRNA)IBA
05/2007
1Connective Tissue Growth FactorIBA
05/2007
1Heparitin Sulfate (Heparan Sulfate)IBA
12/2001
1fragile histidine triad proteinIBA
12/2001
1NucleotidesIBA
12/2001
1carbohydrate-deficient transferrinIBA
11/2001
1Transferrin (beta 2 Transferrin)IBA
11/2001
1Lymphotoxin-betaIBA
09/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2001
1Macrophage Migration-Inhibitory FactorsIBA
09/2001
1InterferonsIBA
09/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2001
1roxatidine acetate (roxatidine)IBA
08/2001
1Cyclin D1IBA
08/2001
1Tuberous Sclerosis Complex 2 ProteinIBA
06/2001
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
06/2001
1CytochromesIBA
06/2001
1Endothelin Receptors (Endothelin Receptor)IBA
04/2001
1Clarithromycin (Biaxin)FDA LinkGeneric
02/2001
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
02/2001
1Etodolac (Lodine)FDA LinkGeneric
02/2001
1TensinsIBA
01/2001
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2001
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2001
1Interleukin-15 (Interleukin 15)IBA
01/2001

Therapy/Procedure

2Stents
08/2006 - 01/2006
1Embolic Protection Devices
09/2008
1Intraperitoneal Injections
05/2007
1Punctures
08/2006
1Chest Tubes (Chest Tube)
02/2004
1Therapeutics
01/2001